iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market
Holding ITOS?
Track your performance easily

iTeos Therapeutics (ITOS) Stock Investors

175 Followers
Based on 764,830 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ITOS
On average, investors allocate 0.00% of their portfolios to ITOS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 764,830 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ITOS

1.7%
Last 7
Days
6.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ITOS, out of 764,830 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ITOS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,632 investors who made their portfolios public
The table shows changes in ITOS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ITOS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Enphase Energy
4.83%
-0.66%
+3.02%
11.82B
Technology
Viking Therapeutics
4.94%
+3.38%
+4.96%
7.04B
Healthcare
Li Auto
5.63%
-1.54%
-3.85%
25.33B
Consumer Cyclical
Merck & Company
3.55%
+0.09%
+5.71%
258.22B
Healthcare
Block
4.32%
-0.26%
+1.17%
44.75B
Technology
Plug Power
5.30%
+0.01%
+0.10%
2.21B
Industrials
DraftKings
5.39%
+0.37%
-0.78%
31.36B
Consumer Cyclical
Bristol-Myers Squibb
3.58%
-0.04%
-2.26%
112.46B
Healthcare
Riot Platforms
5.09%
-0.35%
+1.01%
2.73B
Financial
First Solar
4.56%
+0.67%
+16.22%
22.73B
Technology
Based on the activity of 764,830 active portfolios
Open your Smart Portfolio

ITOS Investor Analysis

ITOS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of ITOS holders
are under 35
Average Segment Performance
Average P/E Ratio23.45
Beta10.33
Dividend Yield51.46%
ITOS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
52.8%
of ITOS holders
are between 35–55
Average Segment Performance
Average P/E Ratio21.88
Beta20.26
Dividend Yield24.92%
ITOS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
36.1%
of ITOS holders
are over 55
Average Segment Performance
Average P/E Ratio21.22
Beta8.93
Dividend Yield41.53%
Overview of age group and performance of ITOS stock investors
See who invests in ITOS according to age group and performance.

FAQ

How many retail Investors hold ITOS?
<0.1% of TipRanks' retail investors hold ITOS in their portfolios.
    What is ITOS Investor Sentiment?
    ITOS’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of ITOS in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of ITOS in the last 7 days.
        What percentage of retail investors changed their holding of ITOS in the last 30 days?
        ▲ 6.0% of TipRanks' retail investors changed their holding of ITOS in the last 30 days.
          What is the average age of retail investors who hold ITOS?
          The average age of ITOS Holders is between 35–55.
            What other stocks have ITOS investors also bought?
            ITOS Investors also bought ENPH, VKTX, LI, MRK, SQ, PLUG, DKNG, BMY, RIOT, FSLR.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AGENAgenus
              AAgilent
              BDXBecton Dickinson
              BIIBBiogen
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis